Billionaire Profile
Peter Grogg
Global Rank
#1103

Image: Public domain | via Wikimedia Commons

Peter Grogg

CEO, Bachem Holding AG
CH
Real-Time Net Worth
$3.63B
As of December 2025
Age
83
Source
Biochemicals
Industry
healthcare
Citizenship
CH

Biography

Peter Grogg (1942-2025) was a Swiss billionaire and the founder of Bachem Holding AG, a global leader in biochemicals and the healthcare industry. His net worth was estimated at $3.63 billion as of December 2025. Grogg's wealth originated from his pioneering work in peptide synthesis, and he played a key role in developing Bachem into a prominent player in the pharmaceutical sector. He was known for his entrepreneurial spirit, innovative approach, and commitment to advancing healthcare through scientific research. His career spanned decades, marked by significant achievements in the field of biochemicals.

Wealth Over Time

In-Depth Profile

Early Life

Peter Grogg was born in Switzerland. From a young age, he displayed an inherent curiosity about the natural world which guided his academic pursuits. This curiosity led him to study chemistry at a Swiss university, providing a solid foundation for his future endeavors.

Rise to Success

In 1971, Grogg founded Bachem Feinchemikalien AG with just two employees in Liestal, Switzerland, with a focus on peptide synthesis. Grogg's vision was to address the growing demand for peptides, which were becoming increasingly important in medical research and pharmaceutical development. Bachem quickly earned a reputation as a reliable supplier of peptides for research and pharmaceutical applications. In 1998, Grogg brought Bachem to the Swiss Stock Exchange. He served as CEO until 2002 and Chairman of the Board of Directors of Bachem Holding AG until 2012.

Key Business Strategies

Grogg's leadership was characterized by a forward-thinking approach and willingness to take risks. He reinvested profits into research and development, enabling Bachem to stay ahead of competitors and expand its capabilities. Grogg expanded the company into non-European markets, establishing Bachem Bioscience, Inc. in Philadelphia, USA, in 1987. Bachem acquired the second-largest manufacturer of peptides, Bachem California, in Torrance, USA, in 1996.

Philanthropy

Grogg was known for his philanthropic endeavors, supporting numerous initiatives in education, healthcare, and environmental conservation.

Career Milestones

1971

Founded Bachem Feinchemikalien AG

Established Bachem with two employees, focusing on peptide synthesis.

1998

Brought Bachem Public

Brought Bachem to the Swiss Stock Exchange.

2002

Stepped Down as CEO of Bachem

Ended his tenure as CEO, after over 30 years in the position.

2012

Ended Tenure as Chairman

Stepped down as Chairman of the Board of Bachem Holding AG.

Philanthropy & Social Impact

Healthcare

Various Initiatives

Unknown

Supported education, healthcare, and environmental conservation

Business Philosophy & Leadership

Leadership Principles

Innovation

Grogg was a pioneer in peptide synthesis and continuously sought innovative processes to improve efficiency and quality.

Entrepreneurial Spirit

Grogg transformed a small venture into a global powerhouse.

Forward-thinking Approach

Grogg's leadership was characterized by his forward-thinking approach and willingness to take risks.